Ensuring Integrity in Clinical Trials: The Role of Small-Box Technology
Niall Balfour, Chief Executive Officer at Tower Cold Chain, explores the role of small box, temperature-controlled containers in the clinical trial market.
The global clinical trials market is rapidly expanding, with recent projections estimating a value of nearly $100 billion by 2030, according to Fortune Business Insights. This growth is spurred by advancements in medical research and development, alongside evolving regulatory landscapes aimed at expediting trial approvals, like those introduced by the MHRA.
In this dynamic environment, the transportation of clinical trial materials – ranging from biological samples to personalised drugs – demands meticulous attention to ensure they maintain their integrity and efficacy until the point of use. Given the high value, perishable nature, and vulnerability of these products to temperature fluctuations and microbial contamination, maintaining a stable and secure environment during transit is paramount.
The implementation of small box, temperature-controlled solutions has emerged as a key strategy in addressing this logistics challenge. Investing in packaging solutions specifically tailored for smaller shipments, with an optimal packaging-to-payload ratio, is vital for navigating the complexities of modern clinical trial supply chains.
Check out our full article: https://journalforclinicalstudies.com/ensuring-integrity-in-clinical-trials-the-role-of-small-box-technology/
